Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.93 | 23.03 |
| PEG Ratio (TTM) | 0.07 | -0.74 |
| P/S Ratio (TTM) | 0.16 | 1.30 |
| P/B Ratio (TTM) | 1.07 | 5.37 |
| P/FCF Ratio (TTM) | -2.32 | 28.13 |
| Price to 5YR AVG Earnings Ratio | N/A | 19.23 |
| Price to 5YR AVG FCF Ratio | N/A | 35.07 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.54% | 7.05% |
| ROE (TTM) | 16.05% | 23.50% |
| Net Profit Margin (TTM) | 2.33% | 5.87% |
| ROIC 5YR AVG | N/A | 23.99% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 39.46% | 81.57% | N/A |
| Revenue | 40.72% | 17.00% | N/A |
| Net Income | 40.17% | 81.68% | N/A |
| Cash Flow | -40.60% | 325.42% | N/A |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.30 | 1.23 |
| Quick Ratio (TTM) | 1.30 | 1.22 |
| D/E Ratio (TTM) | 0.56 | 1.19 |
| Interest Coverage (TTM) | 8.73 | 45.78 |
| Piotroski F-Score | 9 | 6 |
| Altman Z-Score | 3.92 | 3.78 |
| LTL to 5YR AVG FCF | N/A | 7.61 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.42% |